Characterization of factors regulating the activity of hepatocyte growth factor which is being developed for a medicine

正在开发用于药物的肝细胞生长因子活性调节因子的表征

基本信息

  • 批准号:
    09480161
  • 负责人:
  • 金额:
    $ 8.51万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Hepatocyte growth factor (HGF) is a potent factor responsible for liver regeneration, and is being developed for a medicine of liver disease. The activity of HGF is regulated by extracellular and intracellular factors. In this study, we analyzed the function of these factors in regulating the activity of HGF and obtained the following results.(1) HGF activator (HGFA) was identified as a serine protease responsible for activation of HGF after liver injury. Analysis of HGFA after liver injury revealed that amount of HGFA mRNA increased, and HGFA was activated following liver injury.(2) Two types of HGFA inhibitors (HAIs) were identified as potent inhibitors of HGFA.cDNA cloning revealed that both HAIs are serine protease inhibitors with Kunitz domains. Introduction of mutations in the Kunitz domains markedly reduced the activity of HAIs, indicating that the domains are essential for the activity. Immunoblotting analysis demonstrated that HAIs are initially produced in transmembrane forms, and then secreted by the producing cells by proteolytic processing.(3) Hrs and its binding protein (Hbp) were identified as intracellular molecules regulating the activity of HGF.Functional characterization of Hrs/Hbp complexes revealed that the complexes are localized to early endosomes and play an important role in regulating the degradation of HGF and its receptor after internalization. Further, deubiquitinating enzyme UBPY was isolated as a binding partner of the SH3 domain of Hbp, suggesting that UBPY regulates the function of the Hrs/Hbp complexes.
肝细胞生长因子(HGF)是一种有效的肝再生因子,正在开发用于治疗肝脏疾病的药物。HGF的活性受细胞外和细胞内因子的调节。本研究分析了这些因子在调节肝细胞生长因子活性中的作用,得到以下结果。(1)肝细胞生长因子激活因子(HGF activator,HGFA)是一种丝氨酸蛋白酶,在肝损伤后激活肝细胞生长因子。肝损伤后HGFA的分析显示,HGFA mRNA的量增加,并且HGFA在肝损伤后被激活。(2)两种HGFA抑制剂(HAI)被鉴定为HGFA的有效抑制剂,cDNA克隆显示这两种HAI都是具有Kunitz结构域的丝氨酸蛋白酶抑制剂。在Kunitz结构域中引入突变显著降低了HAI的活性,表明该结构域对于活性是必不可少的。免疫印迹分析表明HAI最初以跨膜形式产生,然后由产生细胞通过蛋白水解加工分泌。(3)Hrs及其结合蛋白(Hbp)被鉴定为调节HGF活性的细胞内分子,Hrs/Hbp复合物的功能研究表明,Hrs/Hbp复合物定位于早期内体,在调节HGF及其受体内化后的降解过程中起重要作用。此外,去泛素化酶UBPY被分离为Hbp的SH 3结构域的结合伴侣,表明UBPY调节Hrs/Hbp复合物的功能。

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A.Okajima: "Induction of hepatocyte growth factor activator mRNA in the liver following tissue injury and acute inflammation." Hepatology. 25. 97-102 (1997)
A.Okajima:“组织损伤和急性炎症后肝脏中肝细胞生长因子激活剂 mRNA 的诱导。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
L.Lu: "Human Hrs, a tyrosine kinase substrate in growth factor-stimulated cells : cDNA cloning and mapping of the gene to chromosome 17." Gene. 213. 125-132 (1998)
L.Lu:“人类 Hrs,生长因子刺激细胞中的一种酪氨酸激酶底物:cDNA 克隆以及该基因到 17 号染色体的定位。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Kawaguchi et al.: "Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor." J.Biol.Chem.272. 27558-27564 (1997)
T.Kawaguchi 等人:“2 型肝细胞生长因子激活剂抑制剂(一种 Kunitz 型丝氨酸蛋白酶抑制剂)的纯化和克隆。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Matsubara: "Hepatocyte growth factor activator ; a possible regulator of morphogenesis during the fetal development of rat gastrointestinal tract." Biochem.Biophys.Res.Commun.253. 477-484 (1998)
Y.Matsubara:“肝细胞生长因子激活剂;大鼠胃肠道胎儿发育过程中形态发生的可能调节剂。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Kaibori: "Stimulation of liver regeneration and function after partial hepatectomy in cirrhotic rats by continuous infusion of recombinant human hepatocyte growth factor." J.Hepatology. 27. 381-390 (1997)
M.Kaibori:“通过连续输注重组人肝细胞生长因子,刺激肝硬化大鼠部分肝切除术后的肝脏再生和功能。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KITAMURA Naomi其他文献

KITAMURA Naomi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KITAMURA Naomi', 18)}}的其他基金

Regulation of the endosomal sorting and intracellular signaling ofgrowth factor receptors
生长因子受体内体分选和细胞内信号传导的调节
  • 批准号:
    19370050
  • 财政年份:
    2007
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of regulation of growth factor receptor sorting at endosomes
内体生长因子受体分选调节的分子机制
  • 批准号:
    17370045
  • 财政年份:
    2005
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanism of endosomal sorting of growth factors and receptors
生长因子和受体内体分选的分子机制
  • 批准号:
    15370053
  • 财政年份:
    2003
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Characterization of the regulatory mechanism of endocytosis of growth factors and receptors
生长因子和受体内吞调节机制的表征
  • 批准号:
    13480235
  • 财政年份:
    2001
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Characterization of hepatocyte growth factor activator inhibitors which are being developed for a medicine
正在开发的药物肝细胞生长因子激活剂抑制剂的表征
  • 批准号:
    13557012
  • 财政年份:
    2001
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional characterization of novel regulators of vesicular transport in endocytosis and exocytosis
胞吞作用和胞吐作用中囊泡运输的新型调节剂的功能表征
  • 批准号:
    11480206
  • 财政年份:
    1999
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Characterization of factors regulating the activity of hepatocyte growth factor which is being developed for a medicine
正在开发用于药物的肝细胞生长因子活性调节因子的表征
  • 批准号:
    10557017
  • 财政年份:
    1998
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional characterization of a novel tyrosine phosphorylated protein in signal transduction of hepatocyte growth factor
新型酪氨酸磷酸化蛋白在肝细胞生长因子信号转导中的功能表征
  • 批准号:
    07458164
  • 财政年份:
    1995
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Structural and functional characterization of a novel serine protease responsible for activation of hepatocyte growth factor
负责肝细胞生长因子激活的新型丝氨酸蛋白酶的结构和功能表征
  • 批准号:
    05454625
  • 财政年份:
    1993
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Functional analysis of domain structures of human hepatocyte growth factor
人肝细胞生长因子结构域的功能分析
  • 批准号:
    02454540
  • 财政年份:
    1990
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Role of STING in Cholestatic Liver Injury
STING 在胆汁淤积性肝损伤中的作用
  • 批准号:
    10637131
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
Elucidation of spatiotemporal changes and conversion mechanisms of neutrophil subtypes during liver injury and regeneration
阐明肝损伤和再生过程中中性粒细胞亚型的时空变化和转化机制
  • 批准号:
    23K15436
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of neutrophil-specific NOX2 in alcohol-induced liver injury
中性粒细胞特异性NOX2在酒精性肝损伤中的作用
  • 批准号:
    10621545
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury
EGFR 和 MET 在对乙酰氨基酚诱导的急性肝损伤中的不同作用
  • 批准号:
    10633557
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
Establishment of drug-induced liver injury evaluation system in vivo using humanized liver chimeric mice
人源化肝嵌合小鼠体内药物性肝损伤评价体系的建立
  • 批准号:
    23K05621
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-coding RNA biomarkers to predict liver injury during cancer therapy
非编码 RNA 生物标志物可预测癌症治疗期间的肝损伤
  • 批准号:
    2887812
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Studentship
Investigating the involvement of ferroptosis in neonatal late onset sepsis-induced liver injury
探讨铁死亡与新生儿迟发性脓毒症所致肝损伤的关系
  • 批准号:
    492636
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
Establishment of a database linking compounds and immune responses to understand drug-induced liver injury
建立连接化合物和免疫反应的数据库以了解药物引起的肝损伤
  • 批准号:
    22KJ0984
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
Alcohol-associated cholestatic liver injury and mechanisms
酒精相关胆汁淤积性肝损伤及其机制
  • 批准号:
    10783429
  • 财政年份:
    2023
  • 资助金额:
    $ 8.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了